Skip to content
New: Acetyl-L-Carnitine Benefits: The Real Evidence

Supplements

NMN vs NAD+ vs NR: The Difference Explained

MitoHacker·Updated July 8, 2026·2 min read
Share:

Community Consensus

Community Consensus

Reader sentiment on the compounds this article compares. Votes count toward each compound's own tally.

  1. NAD+
    1.3k votes · 79%👍
  2. NMN
    2.2k votes · 75%👍

Reader sentiment only. Not medical advice, not a recommendation, and not a measure of evidence quality.

Quick answer

NAD+ is the coenzyme your cells actually use for energy; NMN and NR are two precursors your body converts into it. Oral NAD+ is poorly absorbed, so people take a precursor for convenient oral dosing (IV and SubQ NAD+ are well-researched routes, and liposomal oral delivery is still unclear). NR is the most clinically studied and has no regulatory issues; NMN is equally capable of raising NAD+ but its US supplement status is contested. Both reliably raise NAD+; neither has proven clinical benefits in healthy people yet.

Key takeaways

  • NAD+ is the destination coenzyme; NMN and NR are precursors that build it.
  • Oral NAD+ absorbs poorly, so people take a precursor (NR or NMN) for easy oral dosing; IV and SubQ NAD+ are well-researched, and liposomal oral delivery is still unclear.
  • The pathway is NR to NMN to NAD+, but 'closer to NAD+' does not clearly mean 'better'.
  • NR is the most-studied with no regulatory cloud; NMN's US supplement status is contested.
  • Both reliably raise NAD+; clinical benefits in healthy people remain unproven. Exercise raises NAD+ too.

NMN vs NAD+ vs NR: the short answer

These three get used interchangeably, but they’re not the same thing. NAD+ is the destination, the actual coenzyme your cells use for energy. NMN and NR are two different precursors, raw materials your body converts into NAD+. Most people don’t supplement NAD+ orally, because taken by mouth it’s poorly absorbed. Instead you take a precursor, and your cells build NAD+ from it.

What each one actually is

NAD+ (nicotinamide adenine dinucleotide)

The coenzyme itself. Present in every cell, central to converting food into ATP and to DNA repair and sirtuin signaling. NAD+ levels decline with age, which is the entire reason people try to raise them. Here’s the nuance most articles skip: taking NAD+ orally is inefficient because the intact molecule is poorly absorbed. Liposomal oral delivery is being researched, but the evidence remains unclear. IV and SubQ NAD+, on the other hand, are well-researched, established delivery routes. So precursors aren’t used because NAD+ “can’t” be given. They’re used because they offer convenient oral dosing. (See the full NAD+, NR and NMN guide.)

NR (nicotinamide riboside)

A precursor one step “upstream.” NR is the most clinically studied of the boosters. Several human trials confirm it reliably raises NAD+ and is well tolerated.

NMN (nicotinamide mononucleotide)

A precursor one step “downstream” of NR, closer to NAD+ in the pathway. NMN also reliably raises NAD+ in humans. Its wrinkle is regulatory: NMN’s status as a US dietary supplement has been contested, a legal issue rather than a safety verdict.

The pathway (why “closer” doesn’t mean “better”)

The conversion runs roughly: NR → NMN → NAD+. It’s tempting to assume NMN wins because it’s one step nearer the finish line. But cells have efficient transporters for NR, and the research doesn’t cleanly show one precursor beating the other for raising NAD+. Both work. The “which is superior” debate is louder than the evidence.

Side-by-side

NAD+ NR NMN
What it is The coenzyme itself Precursor (upstream) Precursor (downstream)
Taken as an oral supplement? Rarely (oral absorption is poor; IV/SubQ used instead) Yes Yes
Human evidence it raises NAD+ Via IV/SubQ Strong Strong
Most-studied n/a ✓ (most trials) Growing
US regulatory status Clear Clear Contested

So which should you take?

Honestly? For most people the choice matters less than the marketing implies. NR has the deepest human safety and efficacy record and no regulatory cloud, which makes it the more conservative pick. NMN is a reasonable alternative that’s equally capable of raising NAD+, if you’re comfortable with its shifting legal status. What neither reliably delivers yet is proof that raising NAD+ translates into feeling or aging better in healthy people. The biochemistry is solid. The clinical payoff is still being worked out.

The most reliable NAD+ booster remains the free one: exercise, which increases NAD+ turnover through the same pathways.

Educational information only, not medical advice. If you take medication or have a health condition, check with a clinician before supplementing.

Frequently asked questions

Is NMN or NAD+ better to take?

For oral dosing you generally take a precursor like NMN or NR rather than NAD+ itself, because oral NAD+ is poorly absorbed. Your cells convert the precursor into NAD+. So the practical comparison is NMN vs NR, not NMN vs NAD+. (NAD+ itself is given by IV or SubQ, which are well-researched routes.)

What is the difference between NMN and NR?

Both are NAD+ precursors. NR (nicotinamide riboside) is one step upstream and the most clinically studied. NMN (nicotinamide mononucleotide) is one step downstream, closer to NAD+ in the pathway, but its US regulatory status as a supplement has been contested. Both reliably raise NAD+.

Is NMN closer to NAD+ than NR, so is it more effective?

NMN is one step nearer NAD+ in the conversion pathway, but that does not clearly make it more effective. Cells transport and use NR efficiently too, and human research does not cleanly show one precursor outperforming the other for raising NAD+.

Can I just take NAD+ directly?

Not effectively by mouth. The intact NAD+ molecule is large and poorly absorbed orally, which is why oral supplements use precursors (NR or NMN) that cells readily convert into NAD+. Liposomal oral delivery is being researched but the evidence is still unclear. NAD+ itself is administered by IV or SubQ, which are well-researched, established research routes.

References

  1. 1.Rajman L, Chwalek K, Sinclair DA. Therapeutic potential of NAD-boosting molecules: the in vivo evidence. Cell Metab. 2018;27(3):529-547.
  2. 2.Martens CR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018;9:1286.
  3. 3.Yoshino M, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224-1229.
  4. 4.Covarrubias AJ, et al. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2021;22(2):119-141.

Keep reading

Supplements

Acetyl-L-Carnitine Benefits: The Real Evidence

Acetyl-L-carnitine, sold as ALCAR, is L-carnitine with an acetyl group attached, and that single modification is why it exists as a separate product: it crosses the blood-brain barrier more readily than plain L-carnitine. The strongest human evidence is in peripheral neuropathy and depressive symptoms. Two 52-week randomised placebo-controlled trials in 1,257 patients with diabetic neuropathy found improved sural nerve fibre numbers, regenerating fibre clusters, pain and vibratory perception at 1,000 mg three times daily, with more benefit in patients treated earlier. A meta-analysis of 12 trials in 791 participants found reduced depressive symptoms, comparable to standard antidepressants with fewer side effects. It is weakest at the two things it is most often sold for. The dementia trials did not deliver despite a strong acetylcholine mechanism, and a Cochrane review found insufficient evidence to recommend it. Most importantly, in 409 women receiving taxane chemotherapy, 3,000 mg/day of ALCAR made neuropathy significantly worse than placebo, and the effect was still present at 104 weeks. That result means ALCAR should be treated as a compound with specific indications, not a general nerve or brain supplement.

Read →

Supplements

L-Carnitine Side Effects: What Actually Happens

At ordinary supplement doses most people tolerate L-carnitine well. The side effects that do appear are dose-dependent: nausea, abdominal cramping and diarrhoea, plus a fishy body, breath and urine odour that surprises people because it is not an allergy or a bad batch. Gut bacteria convert unabsorbed carnitine into trimethylamine, which smells like rotting fish and leaves the body through sweat and breath, so a shower does not fix it. It is dose-related and fully reverses on stopping. A published risk assessment put the observed safe level at 2,000 mg per day. Four situations deserve real caution rather than a shrug: an existing seizure disorder, thyroid treatment, warfarin, and impaired kidney function. L-carnitine acts as a peripheral antagonist of thyroid hormone, which is why it works against levothyroxine treatment. One question is genuinely unresolved: gut bacteria convert carnitine to TMAO, which accelerated atherosclerosis in mice, while pooled human trials in cardiac patients found lower mortality. Both findings stand. Unusually for a supplement, the certificate of analysis that matters most here confirms isomeric identity rather than potency, because the D-isomer competitively interferes with L-carnitine transport.

Read →

Supplements

How Much Alpha-Lipoic Acid Per Day, and When to Take It

The reference figure is 600 mg per day, and it comes from SYDNEY 2, a trial that compared 600, 1,200 and 1,800 mg of oral alpha-lipoic acid head to head. All three doses improved symptom scores by almost exactly the same amount, roughly 48 to 52 percent against 32 percent on placebo, while nausea, vomiting and vertigo rose steadily with dose. The authors concluded 600 mg once daily gave the best risk-to-benefit ratio, which is why nearly every capsule sold holds that amount. On timing, take it on an empty stomach, about 30 minutes before a meal or two hours after: food both delays and reduces absorption, and alpha-lipoic acid already starts from only about 30 percent absolute bioavailability because the liver extracts most of a dose on first pass. The hour of day matters far less than being fasted, which is the real reason bedtime dosing is popular. Two caveats matter. Those trials studied people with diabetic polyneuropathy, so applying the number to general wellness use is an extrapolation, and the four-year NATHAN 1 trial at 600 mg daily missed its primary endpoint.

Read →